
News|Articles|January 1, 2004
ALLHAT and JNC 7: Health-system applications and economic considerations
New Orleans-The results of the Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack (ALLHAT) Trial, along with the highlights of theSeventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure (JNC 7), were reviewedat an educational session of the recently concluded 38th ASHP Midyear ClinicalMeeting.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Sarcopenia affects patients with ELD, ILD and pulmonary hypertension, new study shows
2
Optum Rx removes reauthorizations from an additional 40 drugs
3
FDA approves $2.59 million gene therapy for SMA
4
Orphan Drug Loophole Shields Blockbuster Drugs From Price Negotiations
5



















































